Predict your next investment

Venture Capital
sneakpeeki.com

See what CB Insights has to offer

Investments

5

About Sneak Peek Investments

Sneak Peek Investments is a venture capital firm that invests in early-stage bio and healthcare technology companies.

Sneak Peek Investments Headquarter Location

508, Teheran-ro, Gangnam-gu Haesung 2 Bldg., Room 1602

Seoul, 06178,

South Korea

+82 02-6951-3660

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Sneak Peek Investments Investments

5 Investments

Sneak Peek Investments has made 5 investments. Their latest investment was in mCureX Therapeutics as part of their Seed VC on June 6, 2021.

CBI Logo

Sneak Peek Investments Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/24/2021

Seed VC

mCureX Therapeutics

$5.74M

Yes

1

7/23/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

3/11/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

$99M

Subscribe to see more

10

Other Investors

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/24/2021

7/23/2020

3/11/2020

Round

Seed VC

Series B

Series B

Other Investors

Other Investors

Company

mCureX Therapeutics

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$5.74M

$99M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

10

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.